Adherence: the journey of medication taking, are we there yet?

被引：11

作者：

Aslani, Parisa ^{[1
]}

Schneider, Marie Paule ^{[2
,3
,4
]}

机构：

[1] Univ Sydney, Fac Pharm, Broadway, NSW 2006, Australia

[2] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland

[3] Univ Lausanne, Sch Pharmaceut Sci, Lausanne, Switzerland

[4] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2014年 / 36卷 / 01期

关键词：

Adherence; Intervention; Persistence;

D O I：

10.1007/s11096-013-9901-x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Patient adherence to medications has been an issue challenging healthcare professionals for decades. Adherence rates, causes of non-adherence, barriers and enablers to medication taking, interventions to promote adherence, and the impact of non-adherence on health outcomes, have been extensively studied. In light of this, the area of adherence research has progressed conceptually and practically. This special issue contains a range of articles which focus on different aspects of adherence, from standardising terminology and methods of measurement, to non-adherence in a broad range of patient populations, and to interventions to promote adherence.

引用

页码：1 / 3

页数：3

共 50 条

[41] Pill taking 'routinization': a critical factor to understanding episodic medication adherence
Ryan, GW
Wagner, GJ
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2003, 15 (06): : 795 - 806
[42] Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam
Tran, Minh-Hoang
Nguyen, Hoang Hai
Mai, Quoc Khanh
Pham, Hong Tham
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (01)
[43] The Journey toward Equality for Women's Sexual Health Research: Are We There Yet?
Kingsberg, Sheryl A.
JOURNAL OF SEXUAL MEDICINE, 2010, 7 (02): : 857 - 857
[44] Journey to find the ideal PET flow tracer for clinical use: Are we there yet?
Glover, David K.
Gropler, Robert J.
JOURNAL OF NUCLEAR CARDIOLOGY, 2007, 14 (06) : 765 - 768
[45] ARE WE THERE YET? THE JOURNEY OF FDG PET IN THE STAGING OF OCULAR ADNEXAL LYMPHOPROLIFERATIVE DISEASE
English, James
Sullivan, Timothy
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 96 - 96
[46] Journey to find the ideal PET flow tracer for clinical use: Are we there yet?
David K. Glover
Robert J. Gropler
Journal of Nuclear Cardiology, 2007, 14 : 765 - 768
[47] Are we there yet? Comment on "Nanopores: A journey towards DNA sequencing" by Meni Wanunu
Bayley, Hagan
PHYSICS OF LIFE REVIEWS, 2012, 9 (02) : 161 - 163
[48] Securities industry and managed investments Are we there yet? The journey of the insider trading provisions
Butler, Jennifer
COMPANY AND SECURITIES LAW JOURNAL, 2008, 26 (07): : 460 - 469
[49] ENHANCING ADHERENCE TO ANTIPSYCHOTIC MEDICATION: WHERE ARE WE GOING WRONG?
Brown, Ellie
Gray, Richard
SCHIZOPHRENIA RESEARCH, 2012, 136 : S173 - S174
[50] The patient's medication access journey: a conceptual framework focused beyond adherence
Holland, Lee
Nelson, Mel L.
Westrich, Kimberly
Campbell, Patrick J.
Pickering, Matthew K.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (12): : 1627 - 1635

← 1 2 3 4 5 →